FDA Device Intelligence
Home › Heraeus Medical GmbH › PALACOS®

PALACOS®

Heraeus Medical GmbH · Model MV+G · UDI-DI 04260102135826

LODMBB Prescription
2
510(k) clearances
13,179
Adverse events (469 deaths)
36
Recalls
82
Facilities

Description

PALACOS® MV+G is indicated for use as bone cement in arthroplasty procedures of the hip, knee and other joints to fix plastic and metal prosthetic parts to living bone when reconstruction is necessary. The cement is indicated for use in the second stage of a two stage revision for total joint arthroplasty after the initial infection has been cleared. PALACOS® MV+G contains the X-ray contrast medium zirconium dioxide. To improve visibility in the surgical field PALACOS® MV+G has been coloured with chlorophyll (E141). The bone cement is prepared directly before use by mixing a polymer powder component with a liquid monomer component. A ductile dough forms which cures within a few minutes.

Recalls

DateFirmReason
2026-08-20Heraeus Medical GmbH (Dental Division)Potential for monomer liquid leakage.
2026-08-20Heraeus Medical GmbH (Dental Division)Potential for monomer liquid leakage.
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2022-11-07Howmedica Osteonics Corp.Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is
2022-11-07Howmedica Osteonics Corp.Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.